Invivyd (IVVD) Total Non-Current Liabilities (2020 - 2024)

Invivyd (IVVD) reported Total Non-Current Liabilities of $62.0 million for Q4 2024, up 21.49% on a YoY basis from $51.0 million in Q1 2024, and down 21.31% quarter-over-quarter from $78.8 million in Q3 2024.

Invivyd (IVVD) Total Non-Current Liabilities (2020 - 2024) Analysis & Trends

Invivyd has reported Total Non-Current Liabilities for 5 years, with the latest figure at $62.0 million in Q4 2024.

  • For the quarter ending Q4 2024, Total Non-Current Liabilities rose 21.49% year-over-year to $62.0 million; the trailing twelve-month figure through Dec 2024 stood at $62.0 million (up 21.49% YoY), and the FY2024 full-year result was $62.0 million, up 21.49% from the prior year.
  • Total Non-Current Liabilities for Q4 2024 stood at $62.0 million, down from $78.8 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $96.9 million in Q1 2022, with the low at $13.1 million in Q4 2020.
  • Historically, Total Non-Current Liabilities has averaged $50.8 million across 5 years, with a median of $49.2 million in 2022.
  • Annual changes were most pronounced in 2021 — Total Non-Current Liabilities jumped 374.4% — and 2022, when it sank 56.18%.
  • Invivyd's Total Non-Current Liabilities stood at $13.1 million in 2020, then jumped by 374.4% to $62.1 million in 2021, then sank by 56.18% to $27.2 million in 2022, then surged by 87.57% to $51.0 million in 2023, then grew by 21.49% to $62.0 million in 2024.
  • The last three Total Non-Current Liabilities figures came in at $62.0 million (Q4 2024), $78.8 million (Q3 2024), and $36.7 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Invivyd 168.41 Mn -58.28 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 61.98 Mn
Sep 30, 2024 78.76 Mn
Jun 30, 2024 36.70 Mn
Mar 31, 2024 36.97 Mn
Dec 31, 2023 51.01 Mn
Sep 30, 2023 27.72 Mn
Dec 31, 2022 27.20 Mn
Sep 30, 2022 47.30 Mn
Jun 30, 2022 69.77 Mn
Mar 31, 2022 96.88 Mn
Dec 31, 2021 62.07 Mn
Dec 31, 2020 13.08 Mn